SCHEMBL1670435

SCHEMBL1670435

O=C(OCc1cc(Br)cc(CF)c1)ON1CCN(CC[S+]([O-])c2ccc3[nH]c(=O)oc3c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 16/20 0.43
KCNH2 Q12809 1/20 0.43
ATXN2 Q99700 9/20 0.39
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
HTR1A P08908 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11899132 0.89 ENPP2 (0.56) ENPP2KCNH2ATXN2
SCHEMBL11899133 0.89 ENPP2 (0.56) ENPP2KCNH2ATXN2
SCHEMBL104877 0.89 ENPP2 (0.55) ENPP2KCNH2ATXN2
SCHEMBL107531 0.86 ENPP2 (0.47) ENPP2KCNH2ATXN2HTR1ASLC6A2
SCHEMBL1671586 0.84 ENPP2 (0.48) ENPP2KCNH2ATXN2
SCHEMBL1672873 0.84 ENPP2 (0.42) ENPP2KCNH2ATXN2GRIN2DGRIN3B
SCHEMBL13137773 0.78 ENPP2 (0.70) ENPP2KCNH2ATXN2
SCHEMBL13137772 0.78 ENPP2 (0.70) ENPP2KCNH2ATXN2
SCHEMBL104876 0.78 ENPP2 (0.70) ENPP2KCNH2ATXN2
SCHEMBL104770 0.74 ENPP2 (0.61) ENPP2KCNH2ATXN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488504-B1 SULFOXIDE DERIVATIVES FOR TREATING TUMORS MERCK PATENT GMBH (DE) 2016-07-06 EP disclosed
EP-2488504-A1 SULFOXIDE DERIVATIVES FOR TREATING TUMORS Merck Patent GmbH (DE) 2012-08-22 EP disclosed
WO-2011044978-A1 SULFOXIDE DERIVATIVES FOR TREATING TUMORS MERCK PATENT GMBH (DE) 2011-04-21 WO disclosed